Long-term survival in adolescent and adult acute lymphoblastic leukemia. 1983

S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli

Among 164 patients with acute lymphoblastic leukemia (ALL) (age greater than 11 years) induced into complete remission at four hospitals in Italy and The Netherlands between 1971-1977, 49 survived for more than three years in continuous complete remission. Features at diagnosis of the 49 long-term survivors were compared with those of the parent group. The long-term survivors presented with significantly lower leukocyte counts and were slightly younger. Late relapses occurred in nine patients after 37-91 months from remission. Of the 45 patients who had all treatment stopped after 24-60 months of continuous remission, seven have relapsed. Relapses, mainly in the marrow, occurred 4-32 months after cessation of therapy, the risk of relapse being greatest in the first year and dropping to zero by the fourth year. ALL appears curable in approximately one fifth of adolescents and adults entering complete remission with adequate chemotherapy.

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
February 1985, Cancer treatment reports,
S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
January 1989, Bone marrow transplantation,
S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
January 1988, Archiv fur Geschwulstforschung,
S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
January 1988, Medical and pediatric oncology,
S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
January 1983, Acta haematologica Polonica,
S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
August 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
July 1978, Pediatria polska,
S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
March 1972, Cancer,
S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
November 2014, Leukemia & lymphoma,
S Amadori, and G Meloni, and M Baccarani, and C Haanen, and R Willemze, and G Corbelli, and A Drenthe-Schonk, and P L Cardozo, and S Tura, and F Mandelli
August 2000, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!